Skip to search formSkip to main contentSkip to account menu

Triton WR-1339

Known as: WR-1339, triton WR 1339 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Hyperlipidaemia is the greatest risk factor of coronary heart disease. Currently available hypolipidaemic drugs have been… 
2011
2011
The antihyperlipidemic activity of the methanol extract (ME) of the leaves of Hibiscus rosa sinensis Linn. against Triton induced… 
1992
1992
Katsuya Obara, MD, Second Department of Internal Medicine, Tohoku University, School of Medicine, 1-1 Seiryo-cho, Aobaku, Sendai… 
1985
1985
The study was undertaken in order to understand the reasons for the distinct differences in the elimination rate of lanthanides… 
1984
1984
Triton WR-1339 was incubated in vitro in various proportions with plasma from normolipidemic rhesus monkeys or with… 
1982
1982
The origin of the lipids accumulated in liver lysosomes after administration of Triton WR-1339 was investigated. When Triton WR… 
1981
1981
Prior administration of Triton WR-1339 (tyloxapol, an anionic surfactant) to noninbred Sprague-Dawley male rats significantly… 
1981
1981
Pretreatment of rats with Triton WR 1339 significantly enhanced the intensity of CC14-induced liver necrosis. Previous workers… 
1979
1979
The antimetastatic effect of Triton WR 1339 (TWR), a nonionic detergent, was evaluated in the rats bearing ascites tumor (Yoshida… 
1973
1973
1. The density-gradient distribution patterns of acid phosphatase, Trypan Blue and denatured (125)I-labelled albumin were studied…